Pipeline & Growth Roadmap

Where Our Innovation Is Headed

Terrain’s pipeline is built on an evolutionary-innovation model: identify a clinical or commercial gap, refine delivery or supply to close it, then expand market access. The roadmap below shows how each focus area feeds that strategy, and when partners can expect new opportunities to reach patients.

(Update cadence: twice per year – May / November.)

2025–2026 Snapshots

Q2 2025

Lidocaine & NSAID hydrogel patches

Q3 2025

High-load stool-softener softgel

Q4 2025

Sleep-aid DIA patch

Q4 2025

Next-gen controlled-release DIA matrix + line extensions

Core Pipeline Grid

Focus Area

Near-Term Actions

Strategic Goal

Pain & Musculoskeletal

Launch NSAID, lidocaine, and other pain-relief patches and gels with partners in 2025

Establish Terrain as the 
go-to non-opioid pain platform

Adjunctive Care

Launch sleep-aid patch with partner and stool-softener softgel internally in 2025

Specialty and dosage-form diversification

Controlled-Release DIA Tech

Advance next-gen delivery matrix with enhanced permeation

Enable higher-strength Rx patches while reducing API load

Pipeline Licensing

Acquire select ANDAs and 505(b)(2) assets

Add fast-track revenue while leveraging existing channels

Data-Driven Distribution

Expand wholesaler and prescriber network footprint

Deepen market visibility and accelerate product pull-through

Partnership Capital

Deploy co-development funds with CMOs & brand owners

Share risk, speed scale-up, and 
secure demand for new capacity

How We Move Ideas to Market

Evaluate

Technical & commercial due diligence, CQA mapping, pathway selection.

Execute

Formulation lock, tech-transfer, regulatory filing, channel staging.

Expand

Line extensions, new packs, and channel deepening for life cycle extension.

Growth, Line Extension, or Liquidity

Option for Terrain to purchase asset or royalty buy-out of mature assets.

Partner Touchpoints

Stage

Ideal Partner Contribution

Terrain Contribution

Concept / Asset Review

Dossier, analytics, cost targets

Market mapping, regulatory gap analysis

Development & Scale-Up

API / tech package, facility access

Formulation IP, CMC, capital, validation support

Launch & Growth

Field insights, demand signals

Distribution, reimbursement, performance reporting